Pharmacology Chemotherapy: General Principles 22ccfc63 Imatinib primarily acts by inhibiting: A BCR-ABL B Tyrosine kinase C PGDFR D None High-Yield Explanation Ans. (B) Tyrosine kinase(Ref: KDT 8th/e p929)Imatinib inhibits tyrosine kinase linked withabl-bcr fusionPDGF receptorc-kit receptor